A. Polychronis

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.

U. Dafni, H. Gogas, C. Markopoulos, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

The Effect of Exemestane on the Lipidemic Profile of Postmenopausal Early Breast Cancer Patients: Preliminary Results of the TEAM Greek Sub-study

H. Gogas, C. Markopoulos, D. Koukouras, 2005, Breast Cancer Research and Treatment.

Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy.

U. Dafni, H. Gogas, C. Markopoulos, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial

U. Dafni, H. Gogas, C. Markopoulos, 2010, Breast Cancer Research.

Adjuvant Cytotoxic and Endocrine Therapy in Pre- and Postmenopausal Patients With Breast Cancer and One to Nine Infiltrated Nodes: Five-Year Results of the Hellenic Cooperative Oncology Group Randomized HE 10/92 Study

K. Kyriakou, A. Adamou, N. Pavlidis, 2004, American journal of clinical oncology.

The effect of exemestane on the lipidemic profile of breast cancer patients: Preliminary results of the TEAM trial Greek sub-study.

H. Gogas, C. Markopoulos, A. Michailidou, 2004, Journal of Clinical Oncology.

The effect of exemestane on the lipidemic profile of breast cancer patients: Preliminary results of the TEAM trial Greek sub-study

H. Gogas, C. Markopoulos, A. Michailidou, 2004 .